New pill hopes to slow rare brain disease MSA

NCT ID NCT06568237

Recruiting now Disease control Sponsor: Teva Branded Pharmaceutical Products R&D LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times

Summary

This study tests an experimental oral drug, TEV-56286, in 350 adults with multiple system atrophy (MSA), a rare and progressive brain disorder. Participants will receive either the drug or a placebo for 48 weeks to see if it slows disease worsening and is safe. The goal is to find a treatment that helps control MSA symptoms and progression.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple system atrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SYSTEM ATROPHY

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Teva Investigational Site 15543
ACTIVE_NOT_RECRUITING

Spokane, Washington, 99202, United States
Teva Investigational Site 15544
ACTIVE_NOT_RECRUITING

Boca Raton, Florida, 33486, United States
Teva Investigational Site 15545
NOT_YET_RECRUITING

Los Angeles, California, 90095, United States
Teva Investigational Site 15546
RECRUITING

Kansas City, Kansas, 66160, United States
Teva Investigational Site 15547
RECRUITING

Washington D.C., District of Columbia, 20007, United States
Teva Investigational Site 15548
RECRUITING

Pittsburgh, Pennsylvania, 15213, United States
Teva Investigational Site 15549
RECRUITING

New York, New York, 10016, United States
Teva Investigational Site 15550
RECRUITING

Chicago, Illinois, 60612-3852, United States
Teva Investigational Site 15551
RECRUITING

New York, New York, 10032-3726, United States
Teva Investigational Site 15552
RECRUITING

Rochester, Minnesota, 55905, United States
Teva Investigational Site 15553
ACTIVE_NOT_RECRUITING

Durham, North Carolina, 27705-4410, United States
Teva Investigational Site 15554
RECRUITING

La Jolla, California, 92037, United States
Teva Investigational Site 15555
RECRUITING

Tampa, Florida, 33613, United States
Teva Investigational Site 15735
NOT_YET_RECRUITING

Hershey, Pennsylvania, 17033, United States
Teva Investigational Site 15736
RECRUITING

Boston, Massachusetts, 02115, United States
Teva Investigational Site 15869
NOT_YET_RECRUITING

Georgetown, Texas, 78628, United States
Teva Investigational Site 15870
NOT_YET_RECRUITING

Farmington Hills, Michigan, 48334, United States
Teva Investigational Site 15873
ACTIVE_NOT_RECRUITING

Alexandria, Virginia, 22310, United States
Teva Investigational Site 15874
RECRUITING

Nashville, Tennessee, 37212, United States
Teva Investigational Site 30294
RECRUITING

Padova, 35127, Italy
Teva Investigational Site 30295
RECRUITING

Salerno, 84131, Italy
Teva Investigational Site 30296
RECRUITING

Roma, 00163, Italy
Teva Investigational Site 30297
RECRUITING

Catania, 95123, Italy
Teva Investigational Site 30298
RECRUITING

Milan, 20132, Italy
Teva Investigational Site 30299
RECRUITING

Bologna, 40139, Italy
Teva Investigational Site 31319
RECRUITING

Valencia, 46026, Spain
Teva Investigational Site 31320
RECRUITING

Pamplona, 31008, Spain
Teva Investigational Site 31321
RECRUITING

Barcelona, 08036, Spain
Teva Investigational Site 31322
RECRUITING

Seville, 41015, Spain
Teva Investigational Site 31323
RECRUITING

Barcelona, 08035, Spain
Teva Investigational Site 31324
RECRUITING

Barcelona, 08041, Spain
Teva Investigational Site 31327
RECRUITING

Madrid, 28006, Spain
Teva Investigational Site 31328
RECRUITING

Barakaldo, 48903, Spain
Teva Investigational Site 31329
RECRUITING

Elche, 03203, Spain
Teva Investigational Site 31330
RECRUITING

Madrid, 28034, Spain
Teva Investigational Site 31331
RECRUITING

Madrid, 28041, Spain
Teva Investigational Site 32818
RECRUITING

Dresden, 01307, Germany
Teva Investigational Site 32819
RECRUITING

Münster, 48149, Germany
Teva Investigational Site 32820
RECRUITING

München, 81377, Germany
Teva Investigational Site 32821
RECRUITING

Ulm, 89081, Germany
Teva Investigational Site 32822
RECRUITING

Düsseldorf, 40225, Germany
Teva Investigational Site 32823
RECRUITING

Beelitz, 14547, Germany
Teva Investigational Site 32824
RECRUITING

Marburg, 35033, Germany
Teva Investigational Site 32825
RECRUITING

Kassel, 34128, Germany
Teva Investigational Site 32826
RECRUITING

Leipzig, 04103, Germany
Teva Investigational Site 35289
RECRUITING

Marseille, 13385, France
Teva Investigational Site 35290
RECRUITING

Bordeaux, 33400, France
Teva Investigational Site 35291
RECRUITING

Paris, 75651 Cedex 13, France
Teva Investigational Site 35292
RECRUITING

Toulouse, 31059, France
Teva Investigational Site 35300
RECRUITING

Caen, 14033, France
Teva Investigational Site 61808
RECRUITING

Belgrade, 11000, Serbia
Teva Investigational Site 80203
RECRUITING

Haifa, 31999, Israel
Teva Investigational Site 80204
RECRUITING

Tel Aviv, 6423906, Israel
Teva Investigational Site 80215
RECRUITING

Jerusalem, 9103102, Israel
Teva Investigational Site 84135
RECRUITING

Sendai, 982-8555, Japan
Teva Investigational Site 84136
RECRUITING

Gifu, 501-1112, Japan
Teva Investigational Site 84137
RECRUITING

Niigata, 951-8520, Japan
Teva Investigational Site 84138
RECRUITING

Sagamihara, 252-0392, Japan
Teva Investigational Site 84139
RECRUITING

Fuchū, 183-0042, Japan
Teva Investigational Site 84140
RECRUITING

Chiba, 260-8677, Japan
Teva Investigational Site 84141
RECRUITING

Sanda-shi, 669-1592, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.